SLRN: Acelyrin, Inc. Stock

by  •  • Comments Off on SLRN: Acelyrin, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 420.38
Enterprise Value ($M) 202.28
Book Value ($M) 656.34
Book Value / Share 6.64
Price / Book 0.64
NCAV ($M) 650.28
NCAV / Share 6.57
Price / NCAV 0.65

Profitability (mra)
Return on Invested Capital (ROIC) -0.58
Return on Assets (ROA) -1.28
Return on Equity (ROE) -1.51

Liquidity (mrq)
Quick Ratio 8.65
Current Ratio 8.65

Balance Sheet (mrq) ($M)
Current Assets 736.64
Assets 742.69
Liabilities 86.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -288.41
Net Income -381.64
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -169.71
Cash from Investing -447.74
Cash from Financing 568.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-19 13G Integrated Core Strategies (us) Llc 4.99
03-28 13G AyurMaya Capital Management Company, LP 9.60
02-14 13G/A Citadel Advisors Llc 6.80
02-13 13G Vanguard Group Inc 6.32
02-09 13G/A Fmr Llc 9.06 -4.67
10-10 13G FIL Ltd 11.11
05-19 13D Westlake BioPartners Fund II, L.P. 10.10
05-19 13D Ai Acel Llc 5.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 211,463 861,544 24.54
2024-05-02 203,260 828,733 24.53
2024-05-01 119,889 1,142,953 10.49
2024-04-30 156,137 250,048 62.44
2024-04-29 75,502 284,449 26.54

(click for more detail)

Similar Companies
SDGR – Schrödinger, Inc. SGMO – Sangamo Therapeutics, Inc.
SLDB – Solid Biosciences Inc. SNDX – Syndax Pharmaceuticals, Inc.
SOPH – SOPHiA GENETICS SA


Financial data and stock pages provided by
Fintel.io